Hospital Universitario de Canarias -ko ikertzaileekin lankidetzan egindako argitalpenak (79)

2024

  1. A Primary Health Care Program and COVID-19. Impact in Hospital Admissions and Mortality

    Journal of General Internal Medicine, Vol. 39, Núm. 14, pp. 2662-2670

  2. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

    Antioxidants, Vol. 13, Núm. 10

  3. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  4. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus

    Life, Vol. 14, Núm. 4

  5. Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 42, Núm. 9, pp. 1773-1780

  6. Retinal vascular events and relationship to CANCER development

    Thrombosis Research, Vol. 244

  7. SIRS criteria versus qSOFA score in patients with severe alcohol-related hepatitis

    Internal and Emergency Medicine

  8. Value of inflammatory response and oxidative damage in the diagnosis of infections in severe alcoholic hepatitis

    European Journal of Internal Medicine, Vol. 119, pp. 64-70

2023

  1. Alpha-Klotho protein in systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47

  2. Author's Reply: “Mean platelet volume is not a useful prognostic biomarker in patients with cirrhosis”

    Digestive and Liver Disease

  3. Author's reply: “Mean platelet volume may not be an indicator for prognosis in patients with alcohol use disorder”

    Digestive and Liver Disease

  4. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  5. Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73

  6. Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction

    Antioxidants, Vol. 12, Núm. 9

  7. Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity

    Diagnostics, Vol. 13, Núm. 20

  8. Mean platelet volume and mortality in patients with alcohol use disorder

    Digestive and Liver Disease, Vol. 55, Núm. 9, pp. 1236-1241

  9. Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis

    Journal of Clinical Medicine, Vol. 12, Núm. 20

  10. Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  11. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

  12. Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

    Life, Vol. 13, Núm. 7